New treatments and increasing drug development are expected to drive market growth. Pharma drug development and government investments will drive...

Submission based on positive results from Phase 3 PHALCON-NERD-301 in which vonoprazan 10 mg and 20 mg controlled heartburn symptoms...

Munich Event Highlights Technology Advancements and Unveils Essential Chips RoadmapMUNICH, Germany, Sept. 26, 2023 (GLOBE NEWSWIRE) -- At its annual...

Paytronix Loyalty Report: 2023 Paytronix Annual Loyalty Report 2023: Loyalty Membership & Revenue Grow as Program Costs Decline Convenience Store...

Available clinical data from the two adult patients dosed with TSHA-102 in the first cohort (low dose) to be discussed...

PRINCETON, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech or the Company), a clinical-stage...

Outpacing Major Competitors, Boomerang Sets a New Benchmark in Grounded Generative AI for Business Applications: Mitigating Hallucinations and Copyright Concerns,...

MINNEAPOLIS, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on...

NORCROSS, Ga., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin-3,...

Major Slimicides Market players include The Dow Chemical Company, Parchem Fine and Specialty Chemicals, Inc., LANXESS, BASF SE, Lonza Group...